SCHEMBL30816404

SCHEMBL30816404

CC(C)(C)OC(=O)N1CCC[C@@H]1Cn1ncc2ccc(F)cc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE8B O95263 1/20 0.44
▸ HTR2A P28223 2/20 0.43
▸ HTR2C P28335 2/20 0.43
▸ APP P05067 1/20 0.43
▸ HTR1A P08908 1/20 0.43
▸ ADRA2A P08913 1/20 0.43
▸ DRD2 P14416 1/20 0.43
▸ ADRA2B P18089 1/20 0.43
▸ ADRA2C P18825 1/20 0.43
▸ SLC6A2 P23975 1/20 0.43
▸ HRH2 P25021 1/20 0.43
▸ HTR1D P28221 1/20 0.43
▸ HTR1B P28222 1/20 0.43
▸ HTR7 P34969 1/20 0.43
▸ DRD3 P35462 1/20 0.43
▸ OPRK1 P41145 1/20 0.43
▸ HTR2B P41595 1/20 0.43
▸ PSEN1 P49768 1/20 0.43
▸ SLC6A3 Q01959 1/20 0.43
▸ TMEM97 Q5BJF2 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30816422 0.87 KDM4E (0.46) PDE8BHTR2AHTR2CHTR2BIRAK4
SCHEMBL27165383 0.84 HTR2A (0.43) HTR2AHTR2CHTR1AHTR1BCHRM2
SCHEMBL27204380 0.84 HTR2A (0.43) HTR2AHTR2CHTR1AHTR1BCHRM2
SCHEMBL27165366 0.78 HTR2A (0.49) HTR2AHTR2CHTR1AHTR1BCHRM2
SCHEMBL27204372 0.78 HTR2A (0.49) HTR2AHTR2CHTR1AHTR1BCHRM2
SCHEMBL27156891 0.76 PDE8B (0.48) PDE8BALOX5APFEN1IRAK4IL1B
SCHEMBL29819701 0.76 PDE8B (0.48) PDE8BALOX5APFEN1IRAK4IL1B
SCHEMBL29819929 0.76 PDE8B (0.48) PDE8BALOX5APFEN1IRAK4IL1B
SCHEMBL22450851 0.74 IL1B (0.49) HTR2AHTR2CAPPHTR1AADRA2A
SCHEMBL27204460 0.73 HTR2A (0.46) HTR2AHTR2CHTR2BCHRM2CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4581018-A1 INDAZOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO Mindset Pharma Inc. (CA) 2025-07-09 — — EP disclosed
WO-2024044848-A1 INDAZOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO MINDSET PHARMA INC. (CA) 2024-03-07 — — WO disclosed
Send feedback